Lung Cancer Drug Tagrisso Shows Real Benefit For Early Stage Lung Cancer Patients With EGFR Mutation

Published Jun 4, 2020

Lung Cancer Drug Tagrisso Shows Real Benefit For Early Stage Lung Cancer Patients With EGFR Mutation

NOW
PLAYING
How Does Bevacizumab (Avastin) Work As Part of Ovarian Cancer Treatment?
NOW
PLAYING
New Hope For Lung Cancer Patients -- FDA Approves Drug Combination Opdivo And Yervoy For First Course Treatment
NOW
PLAYING
Ovarian Cancer - New PARP Inhibitor Combination Drug Approval
NOW
PLAYING
Record Numbers of Cancer Drugs Approved- But Leading Experts Say Vital Clinical Trials Could Drop Off Hugely Due To COVID-19
NOW
PLAYING
PARP Inhibitors for Ovarian Cancer - You Should Understand The Financial Aspects & The Benefits
NOW
PLAYING
You May Be Eligible For a PARP Inhibitor - How to Decide?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.